|Mol Formula||:||C57H83N3O39S / C42H70O35.C15H13N3O4S|
|CAS||:||96684-40-1 / 121696-62-6|
|Functions||:||1. Pharmaceuticals>Musculo-Skeletal Disorders>NSAIDs>Phenyl acetic acid>|
|2. Pharmaceuticals>Musculo-Skeletal Disorders>Rubifacients>|
Progress Life Sciences Pvt. Ltd.(PLS) is a professionally managed rapidly evolving company founded by technocrats with a vision to carry out business globally Piroxicam-β-Cyclodextrin complex. This company has been founded by 1st generation enterprenuers with a strong desire to create a world class generic pharmaceutical and chemical company.
At PLS, we believe that success is defined by the positive impact which we make on the world around us. Since the beginning, our goal has always been to provide access to affordable healthcare solutions to millions of people who are in need.
We are a lean company with skilled,educated & experienced professionals who look after various critical operations on day to day basis and have been successfully able to establish the base for a bigger business platform globally. Our present core focus area remains APIs and intermediates Piroxicam betadex.
Over a period of time PLS has successfully been able to develop new products, gained market approvals, made commercial supplies to customers of reupte in both domestic and international markets & have created a basket which will bring in growh for the company and its people. Our Products are being exported to LATAM, Middle East and Asian subcontinents.
We plan to venture into formulation and finished dosage business and are open for new ideas for collaborations & believe in co-creation of breakthrough solutions Piroxicam-β-Cyclodextrin complex.
Progress curently holds Good manufacturing practices (GMP) license issued by food and drug administration Pune – in accredition to the practices being followed to manufacture the goods therein.
Piroxicam is a nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class used to relieve the symptoms of painful inflammatory conditions like arthritis. Piroxicam works by preventing the production of endogenous prostaglandins which are involved in the mediation of pain, stiffness, tenderness and swelling. The medicine is available as capsules, tablets and (not in all countries) as a prescription-free gel 0.5%. It is also available in a betadex formulation, which allows a more rapid absorption of piroxicam from the digestive tract. Piroxicam is one of the few NSAIDs that can be given parenteral routes.
It was patented in 1968 by Pfizer and approved for medical use in 1979. It became generic in 1992, and is marketed worldwide under many brandnames